glp 1 and glp 2 drugs GLP-1 receptor agonists GLP-1 drugs protect against new

Care Med

Moody, C

95% CI 0.62 to 7.17) (Fig

doi: 10.1161/STROKEAHA.125.053075 Moaket, O.S

Xinhua Qu, [email protected] Specialty section: This article was submitted to Bone Research, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Retratrutide has shown even greater percentage weight loss than other medications in this category and may be an option for those few who did not fully respond or have plateaued on their weight loss from other medications